SCIENTURE HOLDINGS INC (SCNX) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:SCNX • US80880X1046

0.4454 USD
-0.02 (-3.32%)
Last: Feb 5, 2026, 01:39 PM
Fundamental Rating

1

SCNX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. SCNX may be in some trouble as it scores bad on both profitability and health. SCNX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • SCNX had negative earnings in the past year.
  • In the past year SCNX has reported a negative cash flow from operations.
  • In the past 5 years SCNX reported 4 times negative net income.
  • In the past 5 years SCNX always reported negative operating cash flow.
SCNX Yearly Net Income VS EBIT VS OCF VS FCFSCNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

  • The Return On Assets of SCNX (-19.61%) is comparable to the rest of the industry.
  • SCNX has a Return On Equity (-24.86%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -19.61%
ROE -24.86%
ROIC N/A
ROA(3y)-75.75%
ROA(5y)-69.08%
ROE(3y)-1244.95%
ROE(5y)-781.05%
ROIC(3y)N/A
ROIC(5y)N/A
SCNX Yearly ROA, ROE, ROICSCNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

  • SCNX has a better Gross Margin (88.46%) than 94.29% of its industry peers.
  • SCNX's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for SCNX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 88.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-54.95%
GM growth 5Y-41.74%
SCNX Yearly Profit, Operating, Gross MarginsSCNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K -5K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • SCNX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SCNX has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for SCNX has been increased compared to 5 years ago.
  • SCNX has a better debt/assets ratio than last year.
SCNX Yearly Shares OutstandingSCNX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
SCNX Yearly Total Debt VS Total AssetsSCNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • SCNX has an Altman-Z score of -0.80. This is a bad value and indicates that SCNX is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -0.80, SCNX is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.01 indicates that SCNX is not too dependend on debt financing.
  • SCNX has a Debt to Equity ratio of 0.01. This is comparable to the rest of the industry: SCNX outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -0.8
ROIC/WACCN/A
WACC9.24%
SCNX Yearly LT Debt VS Equity VS FCFSCNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 0.19 indicates that SCNX may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.19, SCNX is doing worse than 94.29% of the companies in the same industry.
  • A Quick Ratio of 0.16 indicates that SCNX may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.16, SCNX is not doing good in the industry: 94.29% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.16
SCNX Yearly Current Assets VS Current LiabilitesSCNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The earnings per share for SCNX have decreased strongly by -283.71% in the last year.
  • SCNX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -73.17%.
  • The Revenue for SCNX have been decreasing by -55.05% on average. This is quite bad
EPS 1Y (TTM)-283.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.81%
Revenue 1Y (TTM)-73.17%
Revenue growth 3Y-76.01%
Revenue growth 5Y-55.05%
Sales Q2Q%809.24%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SCNX Yearly Revenue VS EstimatesSCNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
SCNX Yearly EPS VS EstimatesSCNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2020 2021 2022 2023 2024 0 -2 -4 -6 -8 -10

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • SCNX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SCNX Price Earnings VS Forward Price EarningsSCNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SCNX Per share dataSCNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for SCNX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SCIENTURE HOLDINGS INC

NASDAQ:SCNX (2/5/2026, 1:39:13 PM)

0.4454

-0.02 (-3.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-12
Earnings (Next)03-24
Inst Owners1.48%
Inst Owner Change123.64%
Ins Owners10.81%
Ins Owner ChangeN/A
Market Cap18.10M
Revenue(TTM)653.50K
Net Income(TTM)-20.55M
Analysts82.86
Price TargetN/A
Short Float %10.37%
Short Ratio2.37
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend3.08
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 27.69
P/FCF N/A
P/OCF N/A
P/B 0.22
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.72
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0.02
BVpS2.03
TBVpS-0.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.61%
ROE -24.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 88.46%
FCFM N/A
ROA(3y)-75.75%
ROA(5y)-69.08%
ROE(3y)-1244.95%
ROE(5y)-781.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-54.95%
GM growth 5Y-41.74%
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.16
Altman-Z -0.8
F-Score3
WACC9.24%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-283.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-73.17%
Revenue growth 3Y-76.01%
Revenue growth 5Y-55.05%
Sales Q2Q%809.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12808%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46601.3%
OCF growth 3YN/A
OCF growth 5YN/A

SCIENTURE HOLDINGS INC / SCNX FAQ

What is the ChartMill fundamental rating of SCIENTURE HOLDINGS INC (SCNX) stock?

ChartMill assigns a fundamental rating of 1 / 10 to SCNX.


What is the valuation status for SCNX stock?

ChartMill assigns a valuation rating of 0 / 10 to SCIENTURE HOLDINGS INC (SCNX). This can be considered as Overvalued.


How profitable is SCIENTURE HOLDINGS INC (SCNX) stock?

SCIENTURE HOLDINGS INC (SCNX) has a profitability rating of 1 / 10.